147 related articles for article (PubMed ID: 9567457)
1. [Sandostatin treatment in postoperative external digestive fistulae].
Munteanu D; Duca S; Vlad L; Părăian I; Togănel D; Iancu C; Pop F; Radu H; Puia C; Bălă O; Bud O; Nagy Z; Leucă D; Bordei R; Popazu R
Chirurgia (Bucur); 1998; 93(1):13-21. PubMed ID: 9567457
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.
Alivizatos V; Felekis D; Zorbalas A
Hepatogastroenterology; 2002; 49(46):1010-2. PubMed ID: 12143189
[TBL] [Abstract][Full Text] [Related]
3. Role of somatostatin analogues in the management of enterocutaneous fistulae.
Jamil M; Ahmed U; Sobia H
J Coll Physicians Surg Pak; 2004 Apr; 14(4):237-40. PubMed ID: 15228830
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition].
Hernández-Aranda JC; Gallo-Chico B; Flores-Ramírez LA; Avalos-Huante R; Magos-Vázquez FJ; Ramírez-Barba EJ
Nutr Hosp; 1996; 11(4):226-9. PubMed ID: 8962902
[TBL] [Abstract][Full Text] [Related]
5. Causes and management of postoperative enterocutaneous fistulas.
Memon AS; Siddiqui FG
J Coll Physicians Surg Pak; 2004 Jan; 14(1):25-8. PubMed ID: 14764257
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic treatment of postoperative fistulas resistant to conservative management using biological fibrin glue.
Rábago LR; Ventosa N; Castro JL; Marco J; Herrera N; Gea F
Endoscopy; 2002 Aug; 34(8):632-8. PubMed ID: 12173084
[TBL] [Abstract][Full Text] [Related]
7. Enterocutaneous fistula: are treatments improving?
Draus JM; Huss SA; Harty NJ; Cheadle WG; Larson GM
Surgery; 2006 Oct; 140(4):570-6; discussion 576-8. PubMed ID: 17011904
[TBL] [Abstract][Full Text] [Related]
8. Octreotide in the treatment of thoracic duct injuries.
Markham KM; Glover JL; Welsh RJ; Lucas RJ; Bendick PJ
Am Surg; 2000 Dec; 66(12):1165-7. PubMed ID: 11149591
[TBL] [Abstract][Full Text] [Related]
9. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
[TBL] [Abstract][Full Text] [Related]
10. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
Martineau P; Shwed JA; Denis R
Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
[TBL] [Abstract][Full Text] [Related]
11. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease.
Parsi MA; Lashner BA; Achkar JP; Connor JT; Brzezinski A
Am J Gastroenterol; 2004 Mar; 99(3):445-9. PubMed ID: 15056083
[TBL] [Abstract][Full Text] [Related]
12. [The somatostatin analog SMA (201-995) as adjuvant treatment in patients with external fistulae of the digestive system].
Castañón González JA; Miranda Ruíz R; Arías E; Fuentes Pintado E; Zárate Treviño A
Gac Med Mex; 1992; 128(3):285-8. PubMed ID: 1302733
[TBL] [Abstract][Full Text] [Related]
13. Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding.
Chen RJ; Fang JF; Chen MF
Am J Gastroenterol; 1992 Sep; 87(9):1212-5. PubMed ID: 1519586
[TBL] [Abstract][Full Text] [Related]
14. Treatment of external pancreatic fistulas with somatostatin. Second place winner: Conrad Jobst award.
Lansden FT; Adams DB; Anderson MC
Am Surg; 1989 Dec; 55(12):695-8. PubMed ID: 2574557
[TBL] [Abstract][Full Text] [Related]
15. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
[TBL] [Abstract][Full Text] [Related]
16. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
Dobosz M; Dymecki D; Babicki A; Hać S; Gruca Z; Wajda Z
Wiad Lek; 2001; 54(7-8):380-5. PubMed ID: 11641892
[TBL] [Abstract][Full Text] [Related]
17. [Gastrointestinal fistulas. Treatment with a somatostatin analogue (SMS 201-995)].
Gerardo Pérez D; Bernardo Acosta M
G E N; 1994; 48(4):209-18. PubMed ID: 7557275
[TBL] [Abstract][Full Text] [Related]
18. [Esophageal perforation and postoperative fistulae of the upper digestive tract treated endoscopically with the application of Tissucol].
Rábago LR; Castro JL; Joya D; Herrera N; Gea F; Mora P; Blesa C
Gastroenterol Hepatol; 2000 Feb; 23(2):82-6. PubMed ID: 10726389
[TBL] [Abstract][Full Text] [Related]
19. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study.
Scott NA; Finnegan S; Irving MH
Acta Gastroenterol Belg; 1993; 56(3-4):266-70. PubMed ID: 8266769
[TBL] [Abstract][Full Text] [Related]
20. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
Barnett SP; Hodul PJ; Creech S; Pickleman J; Arahna GV
Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
